Analyze Diet
Veterinary and comparative oncology2009; 6(1); 1-18; doi: 10.1111/j.1476-5829.2007.00142.x

Cisplatin: a review of toxicities and therapeutic applications.

Abstract: Cisplatin is a platinum chemotherapeutic used in a variety of malignancies. The antineoplastic activity occurs from DNA cross-links and adducts, in addition to the generation of superoxide radicals. Nephrotoxicity is the most well-known and potentially most clinically significant toxicity. Unfortunately, the mechanism for cisplatin nephrotoxicity has not been completely elucidated; however, many theories have been developed. Other toxicities include gastrointestinal, myelosuppression, ototoxicity and neurotoxicity. Saline diuresis is currently the most accepted way to prevent cisplatin nephrotoxicity. Research has focused on pharmaceuticals and enzyme/molecular alterations as alternatives to long-term diuresis. No agents have currently been identified that can protect from all toxicities. Cisplatin has shown activity against osteosarcoma, transitional cell carcinoma, squamous cell carcinoma (SCC), melanoma, mesothelioma, carcinomatosis and germinal cell tumours in the dog. In the cat, cisplatin cannot be utilized because of fulminant pulmonary oedema that occurs at standard doses. Intralesional cisplatin has been utilized in horses for the treatment of SCC and sarcoids.
Publication Date: 2009-01-31 PubMed ID: 19178659DOI: 10.1111/j.1476-5829.2007.00142.xGoogle Scholar: Lookup
The Equine Research Bank provides access to a large database of publicly available scientific literature. Inclusion in the Research Bank does not imply endorsement of study methods or findings by Mad Barn.
  • Journal Article
  • Review

Summary

This research summary has been generated with artificial intelligence and may contain errors and omissions. Refer to the original study to confirm details provided. Submit correction.

Cisplatin is a platinum-based chemotherapy drug used for treating different types of cancer. While it is effective in attacking cancer cells, its widespread use is limited due to significant toxic side effects such as kidney toxicity, gastrointestinal symptoms, bone marrow suppression, ear damage, and nerve damage. The causes of these side effects are not fully understood and ways to prevent them are yet to be established.

Antineoplastic Activity of Cisplatin

  • Cisplatin works against cancer by interacting with the DNA in cells, creating cross-links and adducts which disrupt DNA function and ultimately lead to cell death.
  • It also induces the generation of superoxide radicals, unstable molecules that can damage cells.
  • The effectiveness of cisplatin has been demonstrated in the treatment of various types of cancer in dogs, including osteosarcoma, transitional cell carcinoma, squamous cell carcinoma, melanoma, mesothelioma, carcinomatosis, and germinal cell tumors.
  • In horses, cisplatin has been used for treating squamous cell carcinoma and sarcoids.

Adverse Effects and Limitations of Cisplatin

  • Cisplatin’s most notorious and potentially most harmful side effect is kidney toxicity, or nephrotoxicity.
  • The exact cause of cisplatin-induced nephrotoxicity remains unclear, but several theories have been proposed, indicating complexity in its mechanism.
  • Other side effects associated with cisplatin include gastrointestinal symptoms (like nausea, vomiting, diarrhea), bone marrow suppression (leading to decreased production of blood cells), ear damage (ototoxicity which can lead to hearing loss), and nerve damage (neurotoxicity).
  • For cats, cisplatin cannot be used due to severe lung edema, a serious condition where fluid accumulates in the lungs.

Managing and Preventing Cisplatin Toxicity

  • The most accepted method to prevent cisplatin-induced kidney damage currently is saline diuresis, a procedure that involves infusion of salt solutions to increase urine production and excretion of cisplatin.
  • There have been efforts to find alternative strategies, including pharmaceutical interventions and genetic/molecular alterations, that could potentially protect against cisplatin toxicities without requiring long-term diuresis.
  • However, no solutions have been found that can effectively protect against all toxic effects of cisplatin.

Cite This Article

APA
Barabas K, Milner R, Lurie D, Adin C. (2009). Cisplatin: a review of toxicities and therapeutic applications. Vet Comp Oncol, 6(1), 1-18. https://doi.org/10.1111/j.1476-5829.2007.00142.x

Publication

ISSN: 1476-5829
NlmUniqueID: 101185242
Country: England
Language: English
Volume: 6
Issue: 1
Pages: 1-18

Researcher Affiliations

Barabas, K
  • Department of Small Animal Clinical Sciences, College of Veterinary Medicine, University of Florida, Gainesville, FL 32610-0126, USA.
Milner, R
    Lurie, D
      Adin, C

        MeSH Terms

        • Animals
        • Antineoplastic Agents / adverse effects
        • Antineoplastic Agents / therapeutic use
        • Cisplatin / adverse effects
        • Cisplatin / therapeutic use
        • Dog Diseases / drug therapy
        • Dogs
        • Horse Diseases / drug therapy
        • Horses
        • Kidney Diseases / chemically induced
        • Kidney Diseases / veterinary
        • Neoplasms / drug therapy
        • Neoplasms / veterinary

        Citations

        This article has been cited 154 times.